Mary B. Cranston is a Retired Senior Partner of Pillsbury Winthrop Shaw Pittman LLP, an international law firm. She was the Chair and Chief Executive Officer of Pillsbury from January 1999 until April 2006, and continued to serve as Chair of the firm until December 2006. She was Firm Senior Partner until January 2012. Ms. Cranston serves as a director of Visa Inc., of the Chemours Company, MyoKardia, Inc., CSAA Insurance, Aretec and Fiduciary Trust. She served as a Trustee of Stanford University from 2000 to 2010, and as Chair of the Board of the Stanford Children’s Hospital and Children’s Health Network until December 2016.

Ms. Cranston holds an AB and JD from Stanford. She has substantial expertise in complex antitrust, class action, and securities law; and she has been recognized by the National Law Journal as one of the 100 most influential lawyers in America. She has also been recognized by the National Association of Corporate Directors as one of the 50 most influential and effective directors in America.